Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

NCT00907296 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Fracture Healing

Interventions

BIOLOGICAL: Romosozumab
DRUG: Placebo

Sponsor

Amgen

Collaborators

[object Object]